ケースで学び病態を理解する頭部外傷の診かた

出版社： 金芳堂
著者：
発行日： 2021-11-04
分野： 臨床医学：一般  >  救命/救急
ISBN： 9784765318815
電子書籍版： 2021-11-04 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：約3営業日

4,840 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

4,840 円(税込)

購入する

商品紹介

エキスパートたちは何をみてどう対応している？
現役のエキスパートたちが経験と知識を集結させ、実際にあった症例から複雑な頭部外傷の病態を、丁寧にわかりやすく解説！
救急専門医、脳外科専門医、研修医の先生らに捧ぐ虎の巻

目次

  • 第1章　疫学：わが国の頭部外傷
    1．はじめに
    2．日本の頭部外傷の現状（JNTDB P2015より）―年齢構成の推移
    3．高齢者（65歳以上）に対する頭部外傷治療と転帰
    4．軽症・中等症頭部外傷
    5．おわりに

    第2章　外傷初期診療の中での脳外科診療
    1．外傷診療の特殊性
    2．標準化された外傷初期診療
    3．primary surveyにおけるDの評価と対応
    4．頭部外傷患者の転送判断と伝達すべき項目
    5．おわりに

    第3章　抗血栓薬内服患者への対応
    1．抗血栓薬内服患者の頭部外傷と初期評価
    2．抗血栓薬の中断・中和
    3．抗血栓薬の種類と中和に際して留意する点
    4．再開のタイミング
    5．おわりに

    第4章　頭部外傷患者における凝固障害への対応
    1．外傷性凝固障害の病態と頭部外傷での特徴
    2．外傷におけるトラネキサム酸のエビデンス
    3．抗血栓薬服用中の患者に対する対応
    4．本CASEの振り返り
    5．おわりに

    第5章　頭部外傷とてんかん
    1．外傷性てんかんの定義
    2．早期発作
    3．てんかん重積状態
    4．外傷性てんかん
    5．おわりに

    第6章　頭部外傷の病態と診断：局所性脳損傷
    1-1．病院前情報の重要性
    1-2．切迫するDと気管挿管
    1-3．画像評価
    1-4．外傷性凝固異常症
    1-5．フォローアップ戦略（定期的画像フォローアップとICPセンサー留置）
    2-1．テント下の局所性脳損傷
    2-2．テント上下に局所性脳損傷が存在する場合
    3．おわりに

    第7章　頭部外傷の病態と診断：びまん性脳損傷
    1．びまん性脳損傷とは
    2．びまん性脳損傷の病態による分類と診断
    3．各論
    4．おわりに

    第8章　頭部外傷の病態と診断：外傷性頭頚部血管障害
    1．総論
    2．各論
    3．おわりに

    第9章　頭部外傷の手術適応と方法：穿頭術
    1．はじめに
    2．ICPセンサー留置術
    3．脳室ドレナージ術
    4．穿頭血腫除去術
    5．おわりに

    第10章　頭部外傷の手術適応と方法：開頭術
    1．手術までの患者の状態把握
    2．手術目的
    3．手術手技
    4．おわりに

    第11章　頭部外傷の手術適応と方法：外傷性髄液漏、視神経管骨折・視神経損傷
    1．外傷性髄液漏
    2．視神経管骨折・視神経損傷
    3．おわりに

    第12章　ICP管理と神経集中治療①基本
    1．はじめに
    2．頭蓋内圧と頭蓋内圧亢進の病態生理
    3．頭蓋内圧モニターについて
    4．おわりに

    第13章　ICP管理と神経集中治療②実践
    1．はじめに
    2．ICP上昇時の治療
    3．ICPモニタリングのトレンド
    4．おわりに

    第14章　頭部外傷と血液バイオマーカー
    1．頭部外傷における採血検査の役割
    2．一般採血における血液バイオマーカー
    3．頭部外傷に特異的な血液バイオマーカー
    4．おわりに

    第15章　小児頭部外傷への対応
    1．小児頭部外傷の特殊性
    2．小児の頭頚部の解剖学的特徴
    3．年齢と受傷機転の特徴
    4．初期診療時の注意点
    5．頭部CT検査の適応基準と考え方
    6．小児重症頭部外傷の集中治療：2019ガイドラインについて
    7．小児重症頭部外傷の治療アルゴリズム
    8．虐待による頭部外傷（AHT）の鑑別
    9．高次脳機能障害・リハビリテーション・フォローアップ
    10．おわりに

    第16章　高齢者頭部外傷への対応
    1．高齢者の頭部外傷の疫学と特徴
    2．高齢者頭部外傷の治療管理のガイドライン
    3．おわりに

    第17章　軽症頭部外傷・脳振盪・スポーツ頭部外傷への対応
    1．搬送時の注意事項
    2．スポーツ頭部外傷の特徴と各種の提言
    3．軽症頭部外傷（スポーツ頭部外傷を含む）における画像診断の適応
    4．スポーツ頭部外傷診療における評価と患者指導の注意点
    5．おわりに

    第18章　高次脳機能障害への対応
    1．外傷後高次脳機能障害の診断基準
    2．頭部外傷後の高次脳機能障害の症状
    3．頭部外傷後の高次脳機能障害の画像診断
    4．頭部外傷後の高次脳機能障害の評価
    5．頭部外傷後の高次脳機能障害に対する薬物療法
    6．頭部外傷後の高次脳機能障害に対するリハビリテーション治療
    7．おわりに

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 疫学 : わが国の頭部外傷

P.9 掲載の参考文献
1) Marshall LF, et al. A new classification of head injury based on computerized tomog-raphy. J Neurosurg. 1991 ; 75 : S14-S20.
 
2) 小野純一, 他. わが国における頭部外傷の最近の動向 : One Week Study 2005と2012の比較検討から. 神経外傷. 2013 ; 36 : 129-135.
 
3) 小野純一, 他. 高齢者頭部外傷の最近の動向 : 頭部外傷データバンクOne Week StudyおよびProject Studyの分析から. 神経外傷. 2015 ; 38 : 1-8.
 
4) 末廣栄一, 他. 頭部外傷データバンク【プロジェクト 2015】の概略. 神経外傷. 2019 ; 42 : 71-88.
 
5) 加藤侑哉, 他. 重症頭部外傷における年齢構成の推移 : 頭部外傷データバンク【プロジェクト 1998, 2004, 2009, 2015】の変遷. 神経外傷. 2019 ; 42 : 160-167.
 
6) 末廣栄一, 他. 高齢者頭部外傷への対応におけるピットフォール-抗血栓薬内服との関連から-. 脳神経外科ジャーナル. 2019 ; 28 : 614-620.
 
7) 宮田昭宏, 他. 交通外傷による重症頭部外傷症例の最近の動向 頭部外傷データバンクにみる疫学的特徴と転帰. 神経外傷. 2019 ; 42 : 109-118.
 
8) 亀山元信, 他. 重症頭部外傷の年齢構成はどのように変化してきたのか? 頭部外傷データバンク【プロジェクト 1998, 2004, 2009】の推移. 神経外傷. 2013 ; 36 : 10-16.
 
9) Saul TG, et al. Effect of intracranial pressure monitoring and aggressive treatment on mortality in severe head injury. J Neurosurg. 1982 ; 56 : 498-503.
PubMed
10) Chesnut RM, et al. A trial of intracranial-pressure monitoring in traumatic brain injury. N Engl J Med. 2012 ; 367 : 2471-2481.
PubMed
11) 本島卓幸, 他. 機械学習による頭部外傷の予後因子の検討 : 頭部外傷データバンクプロジェクト2015より. 神経外傷. 2019 ; 42 : 168-175.
 
12) Farahvar A, et al. Increased mortality in patients with severe traumatic brain injury treated without intracranial pressure monitoring. J Neurosurg. 2012 ; 117 : 729-734.
PubMed
13) Alali AS, et al. Intracranial pressure monitoring in severe traumatic brain injury : Re-sults from the American College of Surgeons Trauma Quality Improvement Program. J Neurotrauma. 2013 ; 30 : 1737-1746.
 
14) Clifton GL, et al. Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med. 2001 ; 344 : 556-563.
PubMed
15) 小畑仁司. わが国における低体温療法/体温管理療法の現況 : 日本頭部外傷データバンク2015の検討. 神経外傷. 2019 ; 42 : 96-102.
 
16) Clifton GL, et al. Very early hypothermia induction in patients with severe brain injury (the National acute brain injury study : Hypothermia II) : A randomised trial. Lancet Neurol. 2011 ; 10 : 131-139.
 
17) Maekawa T, et al. Prolonged mild therapeutic hypothermia versus fever control with tight hemodynamic monitoring and slow rewarming in patients with severe traumatic brain injury : A randomized controlled trial. J Neurotrauma. 2015 ; 32 : 422-429.
PubMed
18) Clifton GL, et al. Early induction of hypothermia for evacuated intracranial he-matomas : a post hoc analysis of two clinical trials. J Neurosurg. 2012 ; 117 : 714-720.
 
19) Suehiro E, et al. Diverse effects of hypothermia therapy in patients with severe trau-matic brain injury based on the computed tomography classification of the traumatic coma data bank. J Neurotrauma. 2015 ; 32 : 353-358.
 
20) Hwang HF, et al. Risk factors for traumatic brain injuries during falls in older persons. J Head Trauma Rehabil. 2015 ; 30 : E9-17.
 
21) Teo DB, et al. Characteristics of fall-related traumatic brain injury in older adults. In-tern Med J 2018 ; 48 : 1048-1055
 
22) 横堀將司, 他. 我が国における高齢者重症頭部外傷の変遷 : 頭部外傷データバンクプロジェクト1998～2015からの検討. 神経外傷. 2018 ; 41 : 71-80.
 
23) Toyoda K, et al. Antithrombotic therapy influences location, enlargement, and mor-tality from intracerebral hemorrhage. The bleeding with antithrombotic therapy (BAT) retrospective study. Cerebrovasc Dis. 2009 ; 27 : 151-159.
 
24) 末廣栄一, 他. 軽症・中等症頭部外傷への対応. 脳神経外科ジャーナル. 2017 ; 26 : 178-184.
 
25) Unden J, et al. Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults : an evidence and consensus-based update. BMC Med. 2013 ; 11 : 50.
PubMed

第2章 外傷初期診療の中での脳外科診療

P.18 掲載の参考文献
1) 日本外傷学会, 他監. 外傷初期診療ガイドライン 改訂第6版. へるす出版. 2021.
 
2) 日本脳神経外科学会, 他監. 頭部外傷治療・管理のガイドライン 第4版. 医学書院. 2019.
 
3) Adzemovic T, et al. Should they stay or should they go? Who benefits from interfacility transfer to a higher-level trauma center following initial presentation at a lower-level trauma center. J Trauma Acute Care Surg. 2019 ; 86 : 952-960.
PubMed

第3章 抗血栓薬内服患者への対応

P.25 掲載の参考文献
1) Ferrera PC, et al. Outcomes of anticoagulated trauma patients. Am J Emerg Med. 1999 ; 17 : 154-156.
PubMed
2) Gaetani P, et al. Traumatic brain injury in the elderly : considerations in a series of 103 patients older than 70. J Neurosurg Sci. 2012 ; 56 : 231-237.
 
3) Albers GW. Atrial fibrillation and stroke. Three new studies, three remaining questions. Arch Intern Med. 1994 ; 154 : 1443-1448.
PubMed
4) Hylek EM, et al. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med. 1994 ; 120 : 897-902.
PubMed
5) Hart RG, et al. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke. 1995 ; 26 : 1471-1477.
PubMed
6) White RH, et al. Major bleeding after hospitalization for deep-venous thrombosis. Am J Med. 1999 ; 107 : 414-424.
PubMed
7) Levine MN, et al. Hemorrhagic complications of anticoagulant treatment. Chest. 2001 ; 119 (1 Suppl) : 108S-121S.
 
8) Saab M, et al. Warfarin and the apparent minor head injury. J Accid Emerg Med. 1996 ; 13 : 208-209.
PubMed
9) Li J BJ, et al. Mild head injury, anticoagulants, and risk of intracranial injury. Lancet. 2001 ; 357 : 771-772.
 
10) Reymond MA, et al. Aspirin as a risk factor for hemorrhage in patients with head injuries. Neurosurg Rev. 1992 ; 15 : 21-25.
PubMed
11) Mina AA, et al. Intracranial complications of preinjury anticoagulation in trauma patients with head injury. J Trauma. 2002 ; 53 : 668-672.
PubMed
12) Davis DP, et al. Head-injured patients who "talk and die" : the San Diego perspective. J Trauma. 2007 ; 62 : 277-281.
 
13) 刈部博, 他. 高齢者頭部外傷におけるtalk and deteriorateのリアル. Neurosurg Emerg. 2020 ; 25 : 187-194.
Medical*Online
14) Itshayek E, et al. Delayed posttraumatic acute subdural hematoma in elderly patients on anticoagulation. Neurosurgery. 2006 ; 58 : E851-E856
 
15) Karni A, et al. Traumatic head injury in the anticoagulated elderly patient : a lethal combination. Am Surg. 2001 ; 67 : 1098-1100.
 
16) Lavoie A, et al. Preinjury warfarin use among elderly patients with closed head injuries in a trauma center. J Trauma. 2004 ; 56 : 802-807.
 
17) Ohm C, et al. Effects of antiplatelet agents on outcomes for elderly patients with traumatic intracranial hemorrhage. J Trauma. 2005 ; 58 : 518-522.
PubMed
18) Cohen DB, et al. Traumatic brain injury in anticoagulated patients. J Trauma. 2006 ; 60 : 553-557.
PubMed
19) Franko J, et al. Advanced age and preinjury warfarin anticoagulation increase the risk of mortality after head trauma. J Trauma. 2006 ; 61 : 107-110.
PubMed
20) Pieracci FM, et al. Degree of anticoagulation, but not warfarin use itself, predicts adverse outcomes after traumatic brain injury in elderly trauma patients. J Trauma. 2007 ; 63 : 525-530.
 
21) Ivascu FA, et al. Predictors of mortality in trauma patients with intracranial hemorrhage on preinjury aspirin or clopidogrel. J Trauma. 2008 ; 65 : 785-788.
PubMed
22) Wong DK, et al. The effects of clopidogrel on elderly traumatic brain injured patients. J Trauma. 2008 ; 65 : 1303-1308.
PubMed
23) Inamasu J, et al. Influence of age and anti-platelet/anti-coagulant use on the outcome of elderly patients with fall-related traumatic intracranial hemorrhage. Neurol Med Chir (Tokyo). 2010 ; 50 : 1051-1055.
PubMed
24) 日本脳神経外科学会, 他. 頭部外傷治療・管理のガイドライン 第4版. 医学書院. 2019, pp173-180.
 
25) Washington CW, et al. Platelet transfusion : An unnecessary risk for mild traumatic brain injury patients on antiplatelet therapy. J Trauma. 2011 ; 71 : 358-363.
PubMed
26) Agyabeng-Dadzie K, et al. Antiplatelet agent reversal is unnecessary in blunt traumatic brain injury patients not requiring immediate craniotomy. Am Surg. 2020 ; 86 : 826-829.
 
27) Beynon C, et al. Clinical review : Traumatic brain injury in patients receiving antiplatelet medication. Crit Care. 2012 ; 16 : 228.
PubMed
28) Powner DJ, et al. Counteracting the effects of anticoagulants and antiplatelet agents during neurosurgical emergencies. Neurosurgery. 2005 ; 57 : 823-831.
PubMed
29) Desborough MJ, et al. Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents : a systematic review and meta-analysis of randomized controlled trials. J Thromb Haemost. 2017 ; 15 : 263-272.
PubMed
30) 矢坂正弘. 抗凝固療法中の出血と中和剤. 血栓止血誌 2020 ; 31 : 584-590.
 
31) Pollack CV Jr, et al. Idarucizumab for dabigatran reversal. N Engl J Med. 2015 ; 373 : 511-520.
PubMed
32) Kirchhof P, et al ; ESC scientific document group. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016 ; 37 : 2893-2962.
 
33) Levy JH, et al ; Subcommittee on control of anticoagulation. When and how to use antidotes for the reversal of direct oral anticoagulants : guidance from the SSC of the ISTH. J Thromb Haemost. 2016 ; 14 : 623-627.
PubMed
34) Grottke O, et al. Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation. Crit Care. 2016 ; 20 : 115.
PubMed
35) Baugh CW, et al. Anticoagulant reversal strategies in the emergency department setting : Recommendations of a multidisciplinary expert panel. Ann Emerg Med. 2020 ; 76 : 470-485.
 
36) Kawamata T, et al. Management of intracranial hemorrhage associated with anticoagulant therapy. Surg Neurol. 1995 ; 44 : 438-443.
PubMed
37) 日本循環器学会. 2020年JCSガイドラインフォーカスアップデート版 冠動脈疾患患者における抗血栓療法. 2020. https://www.j-circ.or.jp/old/guideline/pdf/JCS2020_Kimura_Nakamura.pdf (2021年9月3日閲覧)
 

第4章 頭部外傷患者における凝固障害への対応

P.38 掲載の参考文献
1) Gando S, et al. Pathophysiology of trauma-induced coagulopathy and management of critical bleeding requiring massive transfusion. Semin Thromb Hemost. 2016 ; 42 : 155-165.
PubMed
2) Gando S, et al. Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT/ACOTS). J Thromb Haemost. 2013 ; 11 : 826-835.
PubMed
3) 和田剛志. 重症頭部外傷の血液凝固線溶系-特集 死戦期における血液凝固線溶系の病態生理. Thrombosis medicine. 2019 ; 9 : 23-29.
 
4) Hijazi N, et al. Endogenous plasminogen activators mediate progressive intracerebral hemorrhage after traumatic brain injury in mice. Blood. 2015 ; 125 : 2558-2567.
PubMed
5) Thewke D, et al. Expression of hepatocyte growth factor/scatter factor, its receptor, c-met, and tissue-type plasminogen activator during development of the murine olfactory system. J Neurosci. 1996 ; 16 : 6933-6944.
PubMed
6) Wada T, et al. Disseminated intravascular coagulation with increased fibrinolysis during the early phase of isolated traumatic brain injury. Crit Care. 2017 ; 21 : 219.
PubMed
7) Elodi S, et al. Optimization of conditions for the catalytic effect of the factor IXa-factor VIII complex : probable role of the complex in the amplification of blood coagulation. Thromb Res. 1979 ; 15 : 617-629.
PubMed
8) Hayakawa M, et al. Fibrinogen level deteriorates before other routine coagulation parameters and massive transfusion in the early phase of severe trauma : a retrospective observational study. Semin Thromb Hemost. 2015 ; 41 : 35-42.
PubMed
9) Ziegler B, et al. Efficacy of prehospital administration of fibrinogen concentrate in trauma patients bleeding or presumed to bleed (FIinTIC) : A multicentre, double-blind, placebo-controlled, randomised pilot study. Eur J Anaesthesiol (2020).
PubMed
10) Muradashvili N, et al. Role of fibrinogen in cerebrovascular dysfunction after traumatic brain injury. Brain injury. 2013 ; 27 : 1508-1515.
PubMed
11) Roberts I, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients : an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011 ; 377 : 1096-1101, 1101 e1091-1092.
 
12) Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3) : a randomised, placebo-controlled trial. Lancet. 394, 1713-1723 (2019).
 
13) 和田剛志. 出血性病態とトラネキサム酸 (第3回) CRASH-3 試験とトラネキサム酸. Thrombosis medicine. 2020 ; 10 : 299-303.
 
14) Medcalf RL. The traumatic side of fibrinolysis. Blood. 2015 ; 125 : 2457-2458.
PubMed

第5章 頭部外傷とてんかん

P.48 掲載の参考文献
1) 日本脳神経外科学会, 他監. 頭部外傷治療・管理のガイドライン 第4版. 医学書院. 2019.
 
2) 日本神経学会, 監. てんかん診療ガイドライン 2018. 医学書院. 2018.
 
3) Beniczky S, et al. Unified EEG terminology and criteria for nonconvulsive status epilepticus. Epilepsia. 2013 ; 54 : 28-29.
PubMed
4) Robert S, et. al. A practical clinical definition of epilepsy. Epilepsia. 2014 ; 55 : 475-482.
 

第6章 頭部外傷の病態と診断 : 局所性脳損傷

P.59 掲載の参考文献
1) Patel HC, et al. Specialist neurocritical care and outcome from head injury. Intensive Care Med. 2002 ; 28 : 547-553.
PubMed
2) Gregory WJ Hawryluk, et al. A management algorithm for patients with intracranial pressure monitoring : The Seattle international severe traumatic brain injury consensus conference (SIBICC). Intensive Care Med. 2019 ; 45 : 1783-1794.
 
3) Orito K, et al. Predictive value of leakage signs for pure brain contusional hematoma expansion. J Neurotrauma. 2018 ; 35 : 760-766.
PubMed
4) Baldon IV, et al. The extravasation of contrast as a predictor of cerebral hemorrhagic contusion expansion, poor neurological outcome and mortality after traumatic brain injury : A systematic review and meta-analysis. PLoS One. 2020 ; 15 : e0235561.
PubMed
5) The CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3) : A randomised, placebo-controlled trial. Lancet. 2019 ; 394 : 1713-1723.
 
6) Shibahashi K, et al. Initial results of empirical cryoprecipitate transfusion in the treatment of isolated severe traumatic brain injury : Use of in-house-produced cryoprecipitate. Neurol Med Chir (Tokyo). 2019 ; 59 : 371-378.
PubMed
7) Chesnut RM, et al. A trial of intracranial-pressure monitoring in traumatic brain injury. N Engl J Med. 2012 ; 367 : 2471-2481.
PubMed

第7章 頭部外傷の病態と診断 : びまん性脳損傷

P.68 掲載の参考文献
1) 日本脳神経外科学会, 他監. 頭部外傷治療・管理のガイドライン 第4版. 医学書院. 2019, p115.
 
2) Cooper PR, ed. Head Injury 3rd ed. William & Wilkins. 1993, p140.
 
3) 島克司. 新井一, 他編. 軽症頭部外傷のマネージメント. NS NOW No.17. 神経外傷-Minimum Essentialを押さえよう. メジカルビュー社. 2012, pp31-40.
 
4) 黒岩敏彦, 監訳. グリーンバーグ. 脳神経外科ハンドブック 原著6版. 金芳堂. 2007, pp849-850.
 
5) Gennarelli TA. Influence of the type of intracranial lesion on outcome from severe head injury. J Neurosurg. 1982 ; 56 : 26.
PubMed
6) 太田富雄, 他. 脳神経外科学 (改定12版). 金芳堂. 2016, pp1934-1935.
 
7) Tong KA. Susceptibility-weighted MR imaging : A review of clinical applications in children. AJNR Am J Neuroradiol. 2008 ; 29 : 9-17.
PubMed
8) Moenninghoff C, et al. Diffuse axonal injury at ultra-high field MRI. PLoS One. 2015 ; 10.
PubMed
9) Ezaki Y, et al. Role of diffusion-weighted magnetic resonance imaging in diffuse axonal injury. Acta Radiol. 2006 ; 47 : 733-740.
PubMed
10) Barzo P, et al. Contribution of vasogenic and cellular edema to traumatic brain swelling measured by diffusion-weighted imaging. J Neurosurg. 1997 ; 87 : 900-907.
PubMed
11) Mass AI, et al. Prognostic value of computerized tomography scan characteristics in traumatic brain injury : results from the IMPACT study. J Neurotrauma. 2007 ; 24 : 303-314.
 
12) 卯津羅雅彦. 転帰からみた重症頭部外傷の現状 : 頭部外傷データバンクから. 神経外傷. 2008 ; 31 : 107-112.
 
13) Kramer DR, et al. Cerebral vasospasm in traumatic brain injury. Neurol Res Int. 2013 ; 2013 : 415813.
PubMed
14) Bouma GJ, et al. Pathogenesis of traumatic brain swelling : role of cerebral blood volume. Acta Neurochir Suppl. 1998 ; 71 : 272-275.
PubMed
15) Marmarou A, et al. Predominance of cellular edema in traumatic brain swelling in patients with severe head injuries. J Neurosurg. 2006 ; 104 : 720-730.
PubMed
16) 横堀將司. 頭部外傷の病態と治療. 日本医大会誌. 2019 ; 15.
 
17) Cooper DJ, et al. Decompressive craniectomy in diffuse traumatic brain injury. N Engl J Med. 2011 ; 364 : 1493-1502.
PubMed

第8章 頭部外傷の病態と診断 : 外傷性頭頚部血管障害

P.78 掲載の参考文献
1) 脳神経外科学会, 他監. 頭部外傷治療・管理のガイドライン 第4版. 医学書院. 2019.
 
2) Biffl WL, et al. Blunt cerebrovascular injuries. Curr Probl Surg. 1999 ; 36 : 505-599.
PubMed
3) Miller PR, et al. Prospective screening for blunt cerebrovascular injuries : analysis of diagnostic modalities and outcomes. Ann Surg. 2002 ; 236 : 386-393 ; discussion 393-385.
 
4) Biffl WL, et al. Blunt carotid arterial injuries : implications of a new grading scale. J Trauma. 1999 ; 47 : 845-853.
PubMed
5) Onda H, et al. Traumatic cerebrovascular injury following severe head injury : proper diagnostic timetable and examination methods. Neurol Med Chir (Tokyo). 2013 ; 53 : 573-579.
PubMed
6) Watridge CB, et al. Traumatic carotid artery dissection : diagnosis and treatment. J Neurosurg. 1989 ; 71 : 854-857.
PubMed
7) Krajewski LP, et al. Blunt carotid artery trauma : report of two cases and review of the literature. Ann Surg. 1980 ; 191 : 341-346.
PubMed
8) Yamada S, et al. Carotid artery occlusion due to nonpenetrating injury. J Trauma. 1967 ; 7 : 333-342.
PubMed
9) 森田友安, 他. 問題点の検討-頸椎脱臼骨折に合併した椎骨動脈損傷 (VAI) : VAIは整復前に治療されるべきか. 整形外科. 2018 ; 69 : 357-362.
 
10) Taha JM, et al. Sigmoid sinus thrombosis after closed head injury in children. Neurosurgery. 1993 ; 32 : 541-545 ; discussion 545-546.
 
11) Hesselbrock R, et al. Superior sagittal sinus thrombosis after closed head injury. Neurosurgery. 1985 ; 16 : 825-828.
PubMed
12) Parkinson D, et al. Traumatic intracranial aneurysms. J Neurosurg. 1980 ; 52 : 11-20.
PubMed
13) Salcman M, et al. Giant posttraumatic aneurysm of the intracranial carotid artery : Evolution and regression documented by computed tomography. Neurosurgery. 1985 ; 16 : 218-221.
PubMed
14) Phogat V, et al. Endovascular management of intracranial pseudoaneurysm : an institutional experience. J Cerebrovasc Endovasc Neurosurg. 2020 ; 22 : 211-215.
PubMed
15) Parkinson D. Carotid cavernous fistula : direct repair with preservation of the carotid artery. Technical note. J Neurosurg. 1973 ; 38 : 99-106.
PubMed
16) Nishijima M, et al. Spontaneous occlusion of traumatic carotid cavernous fistula after orbital venography. Surg Neurol. 1985 ; 23 : 489-492.
PubMed
17) 五十嵐豊, 他. 頭部外傷後の多発脳血管攣縮に対し経皮的血管形成術および局所動注療法を施行して良好な結果を得た一例. 日本神経救急学会雑誌. 2012 ; 24 : 91-96.
Medical*Online
18) Oertel M, et al. Posttraumatic vasospasm : the epidemiology, severity, and time course of an underestimated phenomenon : A prospective study performed in 299 patients. J Neurosurg. 2005 ; 103 : 812-824.
PubMed
19) Zubkov AY, et al. Risk factors for the development of post-traumatic cerebral vasospasm. Surg Neurol. 2000 ; 53 : 126-130.
PubMed

第9章 頭部外傷の手術適応と方法 : 穿頭術

P.90 掲載の参考文献
1) 日本脳神経外科学会, 他監. 頭部外傷治療・管理のガイドライン 第4版. 医学書院. 2019.
 
2) Ozdemir M, et al. Anatomy-based navigation for ventriculostomy : Nasion-coronal suture distance measurement. J Clin Exp Invest. 2014 ; 5 : 368-370.
 
3) Nakae R, et al. Time course of coagulation and fibrinolytic parameters in patients with traumatic brain injury. J Neurotrauma. 2016 ; 33 : 688-695.
PubMed
4) Brain Trauma F, et al. Guidelines for the management of severe traumatic brain injury. VII. Intracranial pressure monitoring technology. J Neurotrauma. 2007 ; 24 Suppl 1 : S45-54.
 
5) Chesnut R, et al. Intracranial pressure monitoring : fundamental considerations and rationale for monitoring. Neurocrit Care. 2014 ; 21 Suppl 2 : S64-84.
 
6) Stocchetti N, et al. Traumatic intracranial hypertension. N Engl J Med. 2014 ; 370 : 2121-2130.
PubMed
7) Fried HI, et al. The insertion and management of external ventricular drains : An evidence-based consensus statement : A statement for healthcare professionals from the neurocritical care society. Neurocrit Care. 2016 ; 24 : 61-81.
PubMed
8) Al-Nakshabandi NA. The swirl sign. Radiology. 2001 ; 218 : 433.
PubMed
9) Bergstrom M, et al. Variation with time of the attenuation values of intracranial hematomas. J Comput Assist Tomogr. 1977 ; 1 : 57-63.
PubMed
10) Kloss BT, et al. Acute-on-chronic subdural hematoma. Int J Emerg Med. 2010 ; 3 : 511-512.
PubMed
11) Duret H. Etudes experimentales et cliniques sur les traumatismes cerebraux. Progres Medical. 1878.
 

第10章 頭部外傷の手術適応と方法 : 開頭術

P.105 掲載の参考文献
1) 日本外傷学会, 他監. 外傷初期診療ガイドライン 第5版. へるす出版. 2016.
 
2) 日本脳神経外科学会, 他監. 頭部外傷治療・管理のガイドライン 第4版. 医学書院. 2020.
 
3) Hawryluk GWJ, et al. In reply : Guidelines for the management of severe traumatic brain injury : 2020 update of the decompressive craniectomy recommendations. Neurosurgery. 2021 ; 88 : E372-E373.
PubMed
4) Soto JM, et al. Novel decompressive hemicraniectomy technique for traumatic brain injury : Technical note. World Neurosurgery. 2021 ; 146 : 15-19.
PubMed
5) Yang HS, et al. A faster and wider skin incision technique for decompressive craniectomy : N-shaped incision for decompressive craniectomy. Korean J Neurotrauma. 2016 ; 12 : 72-76.
PubMed
6) Brain trauma fundation ; American association of neurological surgeons ; Congress of neurological surgeons ; AANS/CNS joint section on neurotrauma and critical care. Guidelines for the management of severe traumatic brain injury, 3rd ed. J Neurotrauma. 2007 ; 24 : S1 -S106.
 
7) 川又達朗, 他. 頭蓋内圧制御と減圧開頭術. 特集 頭部外傷治療のスタンダードと問題点. 脳神経外科ジャーナル. 2007 ; 16 : 913-919.
 

第11章 頭部外傷の手術適応と方法 : 外傷性髄液漏、視神経管骨折・視神経損傷

P.113 掲載の参考文献
1) Scholsem M, et al. Surgical management of anterior cranial base fractures with cerebrospinal fluid fistulae : a single-institution experience. Neurosurgery. 2008 ; 62 : 463-469.
PubMed
2) Friedman JA, et al. Post-traumatic cerebrospinal fluid leakage. World J Surg. 2001 ; 25 : 1062-1066.
PubMed
3) Brodie HA, et al. Management of complications from 820 temporal bone fractures. Am J Otol. 1997 ; 18 : 188-197.
PubMed
4) Nandapalan V, et al. Beta-2-transferrin and cerebrospinal fluid rhinorrhoea. Clin Otolaryngol Allied Sci. 1996 ; 21 : 259-264.
PubMed
5) 日本脳神経外科学会, 他監. 頭部外傷治療・管理のガイドライン 第4版. 医学書院. 2019.
 
6) Liu HS, et al. The use of topical intranasal fluorescein in endoscopic endonasal repair of cerebrospinal fluid rhinorrhea.Surg Neurol. 2009 ; 72 : 341-345.
PubMed
7) Seth R, et al. The utility of intrathecal fluorescein in cerebrospinal fluid leak repair. Otolaryngol Head Neck Surg. 2010 ; 143 : 626-632.
PubMed
8) Steinsapir KD. Traumatic optic neuropathy. Curr Opin Ophthalmol. 1999 ; 10 : 340-342.
PubMed
9) Yu-Wai-Man P, et al. Surgery for traumatic optic neuropathy. Cochrane Database Syst Rev. 2013 ; 6 : CD005024.
 
10) Yu-Wai-Man P, et al. Steroids for traumatic optic neuropathy. Cochrane Database Syst Rev. 2013 ; 2013 : CD006032.
 
11) 柳清. 視神経骨折. JOHNS. 2019 ; 35 : 580-584.
 
12) Otani N, et al. Usefulness of Extradural Optic Nerve Decompression via Trans-Superior Orbital Fissure Approach for Treatment of Traumatic Optic Nerve Injury : Surgical Procedures and Techniques from Experience with 8 Consecutive Patients. World Neurosurg. 2016 ; 90 : 357-363.
PubMed

第12章 ICP管理と神経集中治療 (1) 基本

P.126 掲載の参考文献
1) Wilson MH. Monro-Kellie 2.0 : The dynamic vascular and venous pathophysiological components of intracranial pressure. J Cereb Blood Flow Metab. 2016 ; 36 : 1338-1350.
 
2) Garvin R, et al. Emergency neurological life support : Traumatic brain injury. Neurocrit Care. 2015 ; 23 : S143-154.
PubMed
3) 日本脳神経外科学会, 他監. 頭部外傷治療・管理のガイドライン 第4版. 医学書院. 2019.
 
4) Brain trauma foundation : Guidelines for the management of severe traumatic brain injury. J Neurotrauma. 2007 ; 24 : 1-106.
 
5) Garvin R, et al. Emergency neurological life support : Traumatic brain injury. Neurocrit Care. 2015 ; 23 Suppl 2 : S143-154.
 
6) Bullock MR, et al. Guidelines for the management of severe traumatic brain injury. Editor's Commentary.J Neurotrauma. 2007 ; 24 Suppl 1 : 2 p preceding S1.
 
7) Carney N, et al. Guidelines for the management of severe traumatic brain injury, Fourth Edition. Neurosurgery. 2017 ; 80 : 6-15.
PubMed
8) Brain trauma foundation : Guidelines for the management of severe traumatic brain injury. J Neurotrauma. 2007 ; 24 (suppl) : s1-s106.
 
9) 横堀將司. 頭蓋内圧モニタリングと管理 : 頭蓋内圧亢進への対処法. INTENSIVIST. 2013 ; 5 : 525-537.
 
10) Moss E, et al. Effects of changes in mean arterial pressure on SjO2 during cerebral aneurysm surgery. Br J Anaesth. 1995 ; 75 : 527-530.
PubMed
11) Grubhofer G, et al. Jugular venous bulb oxygen saturation depends on blood pressure during cardiopulmonary bypass. Ann Thorac Surg. 1998 ; 65 : 653-657 ; discussion 658.
PubMed
12) Lang EW, et al. Cerebral vasomotor reactivity testing in head injury : The link between pressure and flow. J Neurol Neurosurg Psychiatry. 2003 ; 74 : 1053-1059.
 
13) Petkus V, et al. Association between the outcome of traumatic brain injury patients and cerebrovascular autoregulation, cerebral perfusion pressure, age, and injury grades. Medicina (Kaunas). 2016 ; 52 : 46-53.
PubMed
14) Latronico N, et al. Cerebrovascular reactivity and autonomic drive following traumatic brain injury. Acta Neurochir Suppl. 2008 ; 102 : 3-7.
PubMed
15) Sorrentino E, et al. Critical thresholds for cerebrovascular reactivity after traumatic brain injury. Neurocrit Care. 2012 ; 16 : 258-266.
PubMed
16) Donnelly J, et al. Individualizing Thresholds of Cerebral Perfusion Pressure Using Estimated Limits of Autoregulation. Crit Care Med. 2017 ; 45 : 1464-1471.
PubMed
17) 末廣栄一, 他. 頭部外傷における神経集中治療の理論と実践. 脳神経外科ジャーナル ; 2021 : 30.
 
18) Brady KM, et al. Positive end-expiratory pressure oscillation facilitates brain vascular reactivity monitoring. J Appl Physiol (1985). 2012 ; 113 : 1362-1368.
PubMed
19) Steiner LA, et al. Continuous monitoring of cerebrovascular pressure reactivity allows determination of optimal cerebral perfusion pressure in patients with traumatic brain injury. Crit Care Med. 2002 ; 30 : 733-738.
PubMed
20) Depreitere B, et al. Cerebrovascular Autoregulation Monitoring in the Management of Adult Severe Traumatic Brain Injury : A Delphi Consensus of Clinicians. Neurocrit Care. 2021 Jan 25.
PubMed
21) Harary M, et al. Intracranial pressure monitoring-review and avenues for development. Sensors (Basel). 2018 ; 18 : 465.
PubMed
22) Wijdicks, et al. The practice of emergency and critical care neurology. Oxford University Press. Kindle Edition. 2016 ; 256.
 
23) LUNDBERG N. Continuous recording and control of ventricular fluid pressure in neurosurgical practice. Acta Psychiatr Scand Suppl. 1960 ; 36 : 1-193.
PubMed
24) Harary M, et al. Intracranial pressure monitoring-review and avenues for development. Sensors (Basel). 2018 ; 18 : 465.
PubMed
25) Elwishi M, et al. Monitoring the brain. BJA Educ. 2019 ; 19 : 54-59.
 
26) Matsuda M, et al. Cerebral hemodynamic changes during plateau waves in brain-tumor patients. J Neurosurg. 1979 ; 50 : 483-488.
PubMed
27) Auer LM, et al. Intracranial pressure oscillations (B-waves) caused by oscillations in cerebrovascular volume. Acta Neurochir (Wien). 1983 ; 68 : 93-100.
PubMed

第13章 ICP管理と神経集中治療 (2) 実践

P.140 掲載の参考文献
1) Chesnut RM, et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma. 1993 ; 34 : 216-222.
PubMed
2) Jurgen P, et al. Extracranial complications of severe head injury. J Neurosurg. 1991 ; 75 : S59-S66.
 
3) Carney N, et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery. 2017 ; 80 : 6-15.
PubMed
4) Sorrentino E, et al. Critical thresholds for cerebrovascular reactivity after traumatic brain injury. Neurocrit Care. 2012 ; 16 : 258-266.
PubMed
5) Hawryluk GWJ, et al. A management algorithm for patients with intracranial pressure monitoring : The Seattle international severe traumatic brain injury consensus conference (SIBICC). Intensive Care Med. 2019 ; 45 : 1783-1794.
PubMed
6) Cooper DJ, et al. Decompressive craniectomy in diffuse traumatic brain injury. N Engl J Med. 2011 ; 364 : 1493-1502.
PubMed
7) Hutchinson PJ, et al. Trial of decompressive craniectomy for traumatic intracranial hypertension. N Engl J Med. 2016 ; 375 : 1119-1130.
PubMed
8) Cook AM, et al. Guidelines for the acute treatment of cerebral edema in neurocritical care patients. Neurocrit Care. 2020 ; 32 : 647-666.
PubMed
9) Muizelaar JP, et al. Mannitol causes compensatory cerebral vasoconstriction and vasodilation in response to blood viscosity changes. J Neurosurg. 1983 ; 5 : 822-828.
PubMed
10) Muizelaar JP, et al. Adverse effects of prolonged hyperventilation in patients with severe head injury : A randomized clinical trial. J Neurosurg. 1991 ; 75 : 731-739.
PubMed
11) Timofeev I, et al. Effect of decompressive craniectomy on intracranial pressure and cerebrospinal compensation following traumatic brain injury. J Neurosurg. 2008 ; 108 : 66-73.
PubMed
12) Cooper DJ, et al. Decompressive craniectomy in diffuse traumatic brain injury. N Engl J Med. 2011 ; 364 : 1493-1502.
PubMed
13) Hutchinson PJ, et al. Trial of decompressive craniectomy for traumatic intracranial hypertension. N Engl J Med. 2016 ; 375 : 1119-1130.
PubMed
14) Hawryluk GWJ, et al. Guidelines for the management of severe traumatic brain injury : 2020 update of the decompressive craniectomy recommendations. Neurosurgery. 2020 ; 87 : 427-434.
PubMed
15) Ponce LL, et al. Erythropoietin neuroprotection with traumatic brain injury. Pathophysiology. 2013 ; 20 : 31-38.
PubMed
16) Clifton GL, et al. Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med. 2001 ; 344 : 556-563.
PubMed
17) Clifton GL,et al. Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study : Hypothermia II) : A randomised trial. Lancet Neurol. 2011 ; 10 : 131-139.
 
18) Hutchison JS, et al. Hypothermia therapy after traumatic brain injury in children. N Engl J Med. 2008 ; 358 : 2447-2456.
PubMed
19) Andrews PJ, et al. Hypothermia for intracranial hypertension after traumatic brain injury. N Engl J Med. 2015 ; 373 : 2403-2412.
PubMed
20) Cooper DJ, et al. Effect of early sustained prophylactic hypothermia on neurologic outcomes among patients with severe traumatic brain injury : The POLAR randomized clinical trial. JAMA. 2018 ; 320 : 2211-2220.
PubMed
21) Okonkwo DO, et al. Brain oxygen optimization in severe traumatic brain injury phase-II : A phase II randomized trial. Crit Care Med. 2017 ; 45 : 1907-1914.
 
22) Chesnut R, et al. A management algorithm for adult patients with both brain oxygen and intracranial pressure monitoring : The Seattle international severe traumatic brain injury Consensus Conference (SIBICC). Intensive Care Med. 2020 ; 46 : 919-929.
PubMed
23) Khellaf A, et al. Recent advances in traumatic brain injury. J Neurol. 2019 ; 266 : 2878-2889.
PubMed
24) De Georgia MA. Brain tissue oxygen monitoring in neurocritical care. J Intensive Care Med. 2015 ; 30 : 473-483.
PubMed
25) Fiore M,et al. Role of brain tissue oxygenation (PbtO 2) in the management of subarachnoid haemorrhage : a scoping review protocol. BMJ Open. 2020 ; 10 : e035521.
PubMed

第14章 頭部外傷と血液バイオマーカー

P.148 掲載の参考文献
1) Biomarkers definitions working group. Biomarkers and surrogate endpoints : preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001 ; 69 : 89-95.
 
2) Carlson AP, et al, Low rate of delayed deterioration requiring surgical treatment in patients transferred to a tertiary care center for mild traumatic brain injury. Neurosurg Focus. 2010 ; 29 : E3.
PubMed
3) Laroche M, et al. Coagulopathy after traumatic brain injury. Neurosurgery. 2012 ; 70 : 1334-1345.
PubMed
4) Evran S, et al. The effect of high mobility group box-1 protein on cerebral edema, blood-brain barrier, oxidative stress and apoptosis in an experimental traumatic brain injury model. Brain Res Bull. 2020 ; 154 : 68-80.
 
5) Suehiro E, et al, Treatments for mild and moderate traumatic brain injury. Jpn J Neurosurg. 2017 ; 26 : 178-184.
 
6) Tian H.L, et al. D-dimer as a predictor of progressive hemorrhagic injury in patients with traumatic brain injury : analysis of 194 cases. Neurosurg Rev. 2010 ; 33 : 359-365 ; discussion 365-366.
 
7) Nakae R, et al. Time Course of Coagulation and Fibrinolytic Parameters in Patients with Traumatic Brain Injury. J Neurotrauma. 2016 ; 33 : 688-695.
PubMed
8) Murshid WR. and A.G. Gader, The coagulopathy in acute head injury : comparison of cerebral versus peripheral measurements of haemostatic activation markers. Br J Neurosurg. 2002 ; 16 : 362-369.
 
9) Nekludov M, et al. Coagulation abnormalities associated with severe isolated traumatic brain injury : cerebral arterio-venous differences in coagulation and inflammatory markers. J Neurotrauma. 2007. 24 : 174-180.
PubMed
10) Zhang J, et al. Prognostic role of D-dimer level upon admission in patients with traumatic brain injury. Medicine (Baltimore). 2018 ; 97 : e11774.
PubMed
11) Takayama Y, et al. Pathophysiology, mortality, treatment of acute phase of haemostatic disorders of traumatic brain injury. Jpn J Neurosurg (Tokyo). 2013 ; 22 : 837-841.
 
12) Petzold A. Neurofilament phosphoforms : surrogate markers for axonal injury, degeneration and loss. J Neurol Sci. 2005 ; 233 : 183-198.
 
13) Jafari SS, et al. Axonal cytoskeletal changes after nondisruptive axonal injury. II. Intermediate sized axons. J Neurotrauma. 1998. 15 : 955-966.
PubMed
14) Vajtr D, et al. Immunohistochemistry and serum values of S-100B, glial fibrillary acidic protein, and hyperphosphorylated neurofilaments in brain injuries. Soud Lek. 2012 ; 57 : 7-12.
PubMed
15) Shaw G, et al. Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury. Biochem Biophys Res Commun. 2005 ; 336 : 1268-1277.
PubMed
16) de Kruijk JR, et al. S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients. A comparison with health controls. Acta Neurol Scand. 2001 ; 103 : 175-179.
PubMed
17) Thelin EP, et al. A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury. Acta Neurochir (Wien). 2017 ; 159 : 209-225.
PubMed
18) Raabe A, et al. Serum S-100B protein in severe head injury. Neurosurgery. 1999 ; 45 : 477-483.
PubMed
19) Pelinka LE, et al. GFAP versus S100B in serum after traumatic brain injury : relationship to brain damage and outcome. J Neurotrauma. 2004 ; 21 : 1553-1561.
PubMed
20) Hayakata T, et al. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock. 2004 ; 22 : 102-107.
PubMed
21) Pelinka LE, et al. Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. J Trauma. 2004 ; 57 : 1006-1012.
PubMed
22) Missler U, et al. Measurement of glial fibrillary acidic protein in human blood : analytical method and preliminary clinical results. Clin Chem. 1999 ; 45 : 138-141.
PubMed
23) Mahan MY, et al. Glial fibrillary acidic protein (GFAP) outperforms S100 calcium-binding protein B (S100B) and ubiquitin C-terminal hydrolase L1 (UCH-L1) as predictor for positive computed tomography of the head in trauma subjects. World Neurosurg. 2019 ; 128 : e434-e444.
PubMed
24) Mondello S, et al. Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury : a case control study. Crit Care. 2011 ; 15 : R156.
PubMed
25) Mondello S, et al. Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury. Neurosurgery. 2012 ; 70 : 666-675.
PubMed
26) Folkerts MM, et al. Disruption of MAP-2 immunostaining in rat hippocampus after traumatic brain injury. J Neurotrauma. 1998 ; 15 : 349-363.
PubMed
27) Levin OS, et al. Vasenina, [twenty-five years of the amyloid hypothesis of alzheimer disease : advances, failures and new perspectives]. Zh Nevrol Psikhiatr Im S S Korsakova. 2016 ; 116 : 3-9.
PubMed
28) Tomita K, et al. Tau protein as a diagnostic marker for diffuse axonal injury. PLoS One. 2019 ; 14 : e0214381.
PubMed
29) Langness S, et al. Plasma D-dimer safely reduces unnecessary CT scans obtained in the evaluation of pediatric head trauma. J Pediatr Surg. 2018 ; 53 : 752-757.
PubMed

第15章 小児頭部外傷への対応

P.165 掲載の参考文献
1) Kuppermann N, et al. Identification of children at very low risk of clinically-important brain injuries after head trauma : A prospective cohort study. Lancet. 2009 ; 374 : 1160-1170.
PubMed
2) Easter JS, et al. Comparison of PECARN, CATCH, and CHALICE rules for children with minor head injury : A prospective cohort study. Ann Emerg Med. 2014 ; 2 : 145-152.
PubMed
3) Kochanek PM, et al. Guidelines for the Management of pediatric severe traumatic brain injury, third edition : Update of the brain trauma foundation guidelines. Pediatr Crit Care Med. 2019 ; 3S (Suppl 1) : S1-S82.
 
4) Choudhary AK, et al. Consensus statement on abusive head trauma in infants and young children. Pediatr Radiol. 2018 ; 48 : 1048-1065.
PubMed
5) 日本脳神経外科学会, 他監. 小児頭部外傷. 頭部外傷治療・管理のガイドライン 第4版. 医学書院.2019.
 

第16章 高齢者頭部外傷への対応

P.174 掲載の参考文献
1) 横堀將司, 他. 我が国における高齢者重症頭部外傷の変遷 : 頭部外傷データバンクプロジェクト1998～2015からの検討. 神経外傷. 2018 ; 41 : 71-80.
 
2) 加藤侑哉, 他. 重症頭部外傷における年齢構成の推移 : 頭部外傷データバンク【プロジェクト 1998, 2004, 2009, 2015】の変遷. 神経外傷. 2019 ; 42 : 160-167.
 
3) Raquel CG, et al. Geriatric traumatic brain injury : Epidemiology, outcomes, knowledge gaps, and future directions. J Neurotrauma. 2018 ; 35 : 889-906.
 
4) Reynolds FD, et al. Time to deterioration of the elderly, anticoagulated, minor head injury patient who presents without evidence of neurologic abnormality. J Trauma. 2003 ; 54 : 492-496.
PubMed
5) 榊原陽太郎, 他. Talk & amp ; deteriorate症例の検討 : 自験例の報告と文献的考察. 神経外傷. 2016 ; 39 : 27-31.
 
6) 川又達朗, 他. 頭部外傷性浮腫の最近の進歩とその画像-びまん性と挫傷性浮腫. 神経研究の進歩. 2006 ; 50 : 241-247.
 
7) 末廣栄一, 他. 高齢者頭部外傷への対応におけるピットフォール : -抗血栓薬内服との関連から-. 脳神経外科ジャーナル. 2019 ; 28 : 614-620.
 
8) 末廣栄一, 他. (4) 高齢者頭部外傷治療におけるピットフォール. Neurological Surgery脳神経外科. 2018 ; 46 : 1127-1135.
 
9) 日本脳神経外科学会, 監. 日本脳神経外傷学会. Series. 頭部外傷治療・管理のガイドライン 第4版. 医学書院. 2019.
 
10) Vos Pieter, et al. EFNS guideline on mild traumatic brain injury : Report of an EFNS task force. Eur J Neurol. 2002 ; 9 : 207-219.
 
11) Itshayek E, et al. Delayed posttraumatic acute subdural hematoma in elderly patients on anticoagulation. Neurosurgery. 2006 ; 58E851-856 ; discussion E851-856.
 
12) Nakae R, et al. Time course of coagulation and fibrinolytic parameters in patients with traumatic brain injury. J Neurotrauma. 2016 ; 33 : 688-695.
PubMed
13) Sugimoto K, et al. D-dimer elevation as a blood biomarker for detection of structural disorder in mild traumatic brain injury. J Neurotrauma. 2017 ; 34 : 3245-3248.
 
14) Nakae R, et al. Age-related differences in the time course of coagulation and fibrinolytic parameters in patients with traumatic brain injury. Int J Mol Sci. 2020 ; 21.
PubMed
15) 中江竜太, 他. Talk and Deteriorateの経過を呈した頭部外傷患者におけるD-dimerの検討. 日本救急医学会雑誌. 2014 ; 25 : 247-253.
 
16) Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3) : A randomised, placebo-controlled trial. Lancet. 2019 ; 394 : 1713-1723.
 
17) Cooper DJ, et al. Decompressive craniectomy in diffuse traumatic brain injury. N Engl J Med. 2011 ; 364 : 1493-1502.
PubMed
18) Hutchinson PJ, et al. Trial of decompressive craniectomy for traumatic intracranial hypertension. N Engl J Med. 2016 ; 375 : 1119-1130.
PubMed
19) Haji K, et al. Effect of antithrombotic drugs reversal on geriatric traumatic brain injury. No Shinkei Geka. 2020 ; 48 : 497-504.
PubMed

第17章 軽症頭部外傷・脳振盪・スポーツ頭部外傷への対応

P.186 掲載の参考文献
1) 荻野雅宏, 他. スポーツにおける脳振盪に関する共同声明-第5回国際スポーツ脳振盪会議 (ベルリン, 2016) -解説と翻訳. 神経外傷. 2019 ; 42 : 1-34.
 
2) Swartz EE, et al. National athletic trainers' association position statement : acute management of the cervical spine- injured athlete. J Athl Train. 2009 ; 44 : 306-331.
PubMed
3) Mills BM, et al. Consensus recommendations on the prehospital care of the injured athlete with a suspected catastrophic cervical spine Injury. Clin J Sport Med. 2020 ; 30 : 296-304.
PubMed
4) Mccrory P, et al. Consensus statement on concussion in sport-the 5thinternational conference on concussion in sport held in Berlin, October 2016. Br J Sports Med. 2017 ; 51 : 838-847.
PubMed
5) 永廣信治, 他. スポーツ頭部外傷における脳神経外科医の対応, ガイドライン作成に向けた中間提言. 神経外傷. 2013 ; 36 : 119-128.
 
6) 荒木尚. 中等症・軽症頭部外傷への対応 (特集 Seamlessな頭部外傷診療を目指して) - (特殊な病態・特殊な患者への対応). 救急医学. 2014 ; 38 : 822-826.
 
7) Vos PE, et al. EFNS guideline on mild traumatic brain injury : Report of an EFNS task force. Eur. J.Neurol. 2002 ; 9 : 207-219.
PubMed
8) 日本小児神経学会, 編. 小児頭部外傷時のCT撮像基準の提言・指針. http://jpn-spn.umin.jp/pdf/20191118CTPC.pdf
 
9) Kuppermann N, et al. Identification of children at very low risk of clinically-important brain injuries after head trauma : a prospective cohort study. Lancet. 2009 ; 374 : 1160-1170.
PubMed
10) Osmond MH, et al. CATCH : A clinical decision rule for the use of computed tomography in children with minor head injury. CMAJ. 2010 ; 182 : 341-348.
PubMed
11) Dunning J, et al. Derivation of the children's head injury algorithm for the prediction of important clinical events decision rule for head injury in children. Arch.Dis.Child. 2006 ; 91 : 885-891.
 
12) Echemendia RJ, et al. The sport concussion assessment tool 5th edition (SCAT5) : Background and rationale. Br. J. Sports Med. 2017 ; 51 : 848-850.
PubMed

第18章 高次脳機能障害への対応

P.197 掲載の参考文献
1) 国立障害者リハビリテーションセンター高次脳機能障害情報・支援センター. 高次脳機能障害者支援の手引き (改訂第2版). http://www.rehab.go.jp/brain_fukyu/data/
 
2) 国立障害者リハビリテーションセンター高次脳機能障害情報・支援センター. 障害福祉サービス等事業者向け高次脳機能障害支援マニュアル. http://www.rehab.go.jp/brain_jukyu/data/results/
 
3) 日本脳神経外科学会, 他監. 頭部外傷治療・管理のガイドライン 第4版. 医学書院. 2019 : 198-211 ; 226-228.
 
4) 日本リハビリテーション医学会, 編. リハビリテーション医学・医療用語集 第8版. 文光堂. 2019.
 
5) 上月正博, 他編. リハビリテーションにおける評価 Ver.3. 医歯薬出版. 2016.
 

書評

最近チェックした商品履歴

Loading...